2019 WRI Fellowship Progress Report: NYU School of Medicine

NYUSOM: Drs. Kugler, Rom and Munger Current treatment of idiopathic pulmonary fibrosis (IPF) does not prolong survival. Development of new therapeutic approaches requires improved understanding of the pathogenesis of IPF. We have learned that ‘hedgehog’ (HH) signaling is required for lung development and may be highly relevant to IPF. The clinically-approved HH pathway antagonists Vismodegib […]

Continue reading